Intelligent Investment

Greater Tokyo Market

Global Life Sciences Atlas

April 11, 2025 5 Minute Read

commercial-real-estate-Tokyo

Overview

  • Greater Tokyo offers Japan’s most comprehensive life sciences industry presence from research and development (R&D) to front office and headquarters locations.
  • Greater Osaka also offer a significant Japanese life sciences industry presence, but not to the same degree as Greater Tokyo.
  • Strong growth in Japanese R&D expenditures in recent years has coincided with growing interest in leasable lab spaces, as more companies look to restructure their R&D facilities/systems to allow for more collaboration with other companies/institutes as well as to enhance staffing.

Submarkets

Tokyo-Submarket-Map

  • Total leasable space of wet labs in the Greater Tokyo Area is estimated to be 134,000 tsubo (c. 4.8 million sq.ft.), many of which are concentrated in Yokoyama and Kawasaki.
  • New construction lab rents, Tokyo CBD $49-$54.

Figure 1: Number of Life Science Related Researchers in Japan

Source: Ministry of Internal Affairs and Communications, 2024.

Figure 2: Leasable space of wet labs in Greater Tokyo (‘000 tsubo)

Source: CBRE estimate based on publicly disclosed information, October, 2024.

Life Sciences Venture Capital Investment Trends

Figure 3: Greater Tokyo Life Sciences Venture Capital Funding

Source: Pitchbook, CBRE Research, Q1 2025.

Life Sciences Market Stats

Figure 4: Leasable space of wet labs by City (‘000 tsubo)

Source: CBRE estimate based on publicly disclosed information, October, 2024.
  • Astellas Pharma Inc.
  • Chugai Pharmaceutical Co., Ltd.
  • Daiichi Sankyo, Inc.
  • Eisai Co., Ltd.
  • Fujifilm Holdings Corp.
  • Kyowa Kirin Co., Ltd.
  • Ono Pharmaceutical Co., Ltd.
  • Otsuka Pharmaceutical Co., Ltd.
  • Shionogi & Co., Ltd.
  • Sumitomo Pharma Co., Ltd.
  • Takeda Therapeutics

Global Life Science Markets

  • Local Response | Intelligent Investment

    Beijing Market

    April 11, 2025

    commercial-real-estate-Beijing

    Beijing is one of China’s two comprehensive life sciences clusters, alongside Shanghai, that offer a spectrum of research and development (R&D), manufacturing, medical technology and front office or headquarters space.

  • Local Response | Intelligent Investment

    Shanghai Market

    April 11, 2025

    commercial-real-estate-Shanghai

    Shanghai stands as one of China’s two comprehensive life sciences clusters, alongside Beijing, offering a spectrum of research and development (R&D).

  • Local Response | Intelligent Investment

    Singapore Market

    April 11, 2025

    commercial-real-estate-Singapore

    Singapore is one of the few markets in Asia-Pacific with a full end-to-end value chain—manufacturing, research and development (R&D), sales and logistics.